Literature DB >> 8779995

Differential effect of three commercial heparins on Na+/H+ exchange and growth of PASMC.

C G Dahlberg1, B T Thompson, P M Joseph, H G Garg, C R Spence, D A Quinn, J V Bonventre, C A Hales.   

Abstract

Heparin preparations vary in chemical content and in antiproliferative activity for pulmonary artery smooth muscle cells (PASMC). Intracellular alkalinization via stimulation of the Na+/H+ antiporter appears to be a permissive event for proliferation of PASMC. We wondered whether the variable effect of heparin preparations on PASMC growth might be due to different degrees of inhibition of the Na+/H+ antiporter and whether variations in chemical formulation might correlate with the inhibition. Fluorescent microscopy of bovine PASMC was done using a dye with which fluorescence varies directly with intracellular pH (pHi). Bovine PASMC were preincubated with three heparin preparations previously shown to vary in antiproliferative activity, at 1.0 microgram/ml for 24 h. Platelet-derived growth factor (PDGF; 60 ng/ml) on PASMC without heparin resulted in a rise in pHi of 0.27 +/- 0.02 pH units. The rise in pH units in heparin-treated PASMC was 0.34 +/- 0.03 with Choay, 0.21 +/- 0.02 with Elkins-Sinn, and 0.07 +/- 0.02 with Upjohn (+/-SE; all P < 0.05; n = 5). Upjohn heparin incubation for as little as 15 min still impeded the rise in pH induced by PDGF. Heparin did not block the Na+/H+ exchanger directly, as it still restored pHi in response to an acid load. Compared with PASMC proliferation induced by 60 ng/ml PDGF, 1 microgram/ml of Choay, Elkins-Sinn, and Upjohn heparin produced -4 +/- 7.4, 1.4 +/- 4.8, and 48 +/- 2.2% inhibition of PDGF control, respectively (P < 0.05 for Upjohn compared with PDGF and Choay). The heparins varied in protein content and amino acid composition. However, amino acid and glucosamine composition, total sulfation, and extent of 3-O-sulfation did not predict their activity. Thus inhibition of PDGF activation of the Na+/H+ antiporter by a given heparin preparation correlated well with its ability to inhibit PASMC proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779995     DOI: 10.1152/ajplung.1996.270.2.L260

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Craig Freeman; Boyangzi Li; Fuming Zhang; Robert J Linhardt; Charles A Hales
Journal:  Carbohydr Res       Date:  2010-03-21       Impact factor: 2.104

2.  Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.

Authors:  Hari G Garg; Charles A Hales; Lunyin Yu; Melissa Butler; Tasneem Islam; Jin Xie; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2006-08-22       Impact factor: 2.104

3.  Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Charles A Hales; Boyangzi Li; Casey N Moore; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2011-07-20       Impact factor: 2.916

4.  Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling.

Authors:  Lunyin Yu; Deborah A Quinn; Hari G Garg; Charles A Hales
Journal:  Am J Respir Crit Care Med       Date:  2008-02-28       Impact factor: 21.405

5.  Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Craig Freeman; Boyangzi Li; Fuming Zhang; Robert J Linhardt; Charles A Hales
Journal:  Carbohydr Res       Date:  2008-07-04       Impact factor: 2.104

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.